Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R James White

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Hypertension (Dallas, Tex. : 1979)|August 25, 2020
Endothelial-to-Mesenchymal Transition and Inflammation Play Key Roles in Cyclophilin A-Induced Pulmonary Arterial HypertensionChao Xue, Sharon Senchanthisai, Mark Sowden, et al.
Hand (New York, N.Y.)|April 1, 2021
Evaluation of Clinical Recovery After Surgical Treatment for Hand Ischemia From Vasospastic and Occlusive Disease Using PROMISDavid N Bernstein, John A Cliburn, Daniel J Lachant, et al.
Journal of Thrombosis and Haemostasis : JTH|January 15, 2021
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infectionDaniel J Lachant, Neil A Lachant, Peter Kouides, et al.
Pulmonary Circulation|September 13, 2023
Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertensionDaniel Lachant, Allison Light, Michael Lachant, et al.
Pulmonary Circulation|December 7, 2020
Clinical trial design in phase 2 and 3 trials for pulmonary hypertensionSylvia Nikkho, Peter Fernandes, R James White, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|October 31, 2021
An untapped resource: characteristics of thrombus recovered from intermediate or high risk pulmonary embolus patientsGeoffrey Newcomb, Bennett L Wilson, R James White, et al.
JHLT Open|March 27, 2025
Angiopoietin-2 and D-dimer add prognostic information to clinical risk in pulmonary arterial hypertensionHeather L Clark, Daniel Lachant, Allison N Light, et al.
Pulmonary Circulation|March 10, 2026
Longitudinal Remote 6-Minute Walk Distance and Cardiac Effort Using Wearable Sensors in Pulmonary HypertensionDaniel Lachant, Nishit Agarwal, Kyle Norton, et al.
Experimental Lung Research|January 31, 2018
Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized ratsDaniel J Lachant, David F Meoli, Deborah Haight, et al.
The American Journal of Pathology|May 10, 2011
Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging miceMin Yee, R James White, Hani A Awad, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Hypertension (Dallas, Tex. : 1979)|August 25, 2020
Endothelial-to-Mesenchymal Transition and Inflammation Play Key Roles in Cyclophilin A-Induced Pulmonary Arterial HypertensionChao Xue, Sharon Senchanthisai, Mark Sowden, et al.
Hand (New York, N.Y.)|April 1, 2021
Evaluation of Clinical Recovery After Surgical Treatment for Hand Ischemia From Vasospastic and Occlusive Disease Using PROMISDavid N Bernstein, John A Cliburn, Daniel J Lachant, et al.
Journal of Thrombosis and Haemostasis : JTH|January 15, 2021
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infectionDaniel J Lachant, Neil A Lachant, Peter Kouides, et al.
Pulmonary Circulation|September 13, 2023
Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertensionDaniel Lachant, Allison Light, Michael Lachant, et al.
Pulmonary Circulation|December 7, 2020
Clinical trial design in phase 2 and 3 trials for pulmonary hypertensionSylvia Nikkho, Peter Fernandes, R James White, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|October 31, 2021
An untapped resource: characteristics of thrombus recovered from intermediate or high risk pulmonary embolus patientsGeoffrey Newcomb, Bennett L Wilson, R James White, et al.
JHLT Open|March 27, 2025
Angiopoietin-2 and D-dimer add prognostic information to clinical risk in pulmonary arterial hypertensionHeather L Clark, Daniel Lachant, Allison N Light, et al.
Pulmonary Circulation|March 10, 2026
Longitudinal Remote 6-Minute Walk Distance and Cardiac Effort Using Wearable Sensors in Pulmonary HypertensionDaniel Lachant, Nishit Agarwal, Kyle Norton, et al.
Experimental Lung Research|January 31, 2018
Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized ratsDaniel J Lachant, David F Meoli, Deborah Haight, et al.
The American Journal of Pathology|May 10, 2011
Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging miceMin Yee, R James White, Hani A Awad, et al.
Pageof 7